RhumbLine Advisers’s Viemed Healthcare VMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $356K | Buy |
51,456
+4,228
| +9% | +$29.2K | ﹤0.01% | 2889 |
|
2025
Q1 | $344K | Buy |
47,228
+392
| +0.8% | +$2.85K | ﹤0.01% | 2810 |
|
2024
Q4 | $376K | Buy |
46,836
+6,275
| +15% | +$50.3K | ﹤0.01% | 2846 |
|
2024
Q3 | $297K | Sell |
40,561
-1,450
| -3% | -$10.6K | ﹤0.01% | 3032 |
|
2024
Q2 | $275K | Buy |
42,011
+3,613
| +9% | +$23.7K | ﹤0.01% | 3050 |
|
2024
Q1 | $362K | Buy |
38,398
+1,350
| +4% | +$12.7K | ﹤0.01% | 2866 |
|
2023
Q4 | $291K | Sell |
37,048
-954
| -3% | -$7.49K | ﹤0.01% | 2993 |
|
2023
Q3 | $256K | Buy |
38,002
+1,713
| +5% | +$11.5K | ﹤0.01% | 3017 |
|
2023
Q2 | $355K | Buy |
+36,289
| New | +$355K | ﹤0.01% | 2901 |
|
2022
Q2 | – | Sell |
-42,419
| Closed | -$211K | – | 3244 |
|
2022
Q1 | $211K | Sell |
42,419
-3,846
| -8% | -$19.1K | ﹤0.01% | 2743 |
|
2021
Q4 | $242K | Sell |
46,265
-223
| -0.5% | -$1.17K | ﹤0.01% | 2778 |
|
2021
Q3 | $258K | Buy |
46,488
+436
| +0.9% | +$2.42K | ﹤0.01% | 2825 |
|
2021
Q2 | $329K | Buy |
46,052
+9,109
| +25% | +$65.1K | ﹤0.01% | 2752 |
|
2021
Q1 | $374K | Sell |
36,943
-1,780
| -5% | -$18K | ﹤0.01% | 2620 |
|
2020
Q4 | $300K | Buy |
38,723
+3,064
| +9% | +$23.7K | ﹤0.01% | 2660 |
|
2020
Q3 | $308K | Sell |
35,659
-2,082
| -6% | -$18K | ﹤0.01% | 2509 |
|
2020
Q2 | $362K | Buy |
+37,741
| New | +$362K | ﹤0.01% | 2475 |
|